Size of the IARC multicentre case–control study and human papillomavirus (HPV) DNA prevalence
| Cervical cancer | ||||||
|---|---|---|---|---|---|---|
| Controls | Adeno and mixed | Squamous | ||||
| No. countries | N | HPV DNA (% +ve) | N | HPV DNA (% +ve) | N | HPV DNA (% +ve) |
| *Brazil, Morocco, Paraguay, the Philippines, Thailand, Peru, Mali, Spain, and Colombia. | ||||||
| †Brazil, Morocco, Paraguay, the Philippines, Thailand, and Peru. | ||||||
| 9* | 2491 | 13.4 | – | – | 2365 | 90.7 |
| 6† | 1466 | 15.4 | 141 | 91.9 | 2280 | 96.6 |